A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder

NCT00635531 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped Please see Detailed Description for termination reason.

Conditions

Panic Disorder

Interventions

OTHER: placebo
DRUG: alprazolam XR

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.